[{"id":"6ad1964d-0f6f-4cdd-938e-6b965c825842","acronym":"DB-1310-O-1001","url":"https://clinicaltrials.gov/study/NCT05785741","created_at":"2023-03-27T20:03:40.439Z","updated_at":"2024-07-02T16:35:18.020Z","phase":"Phase 1/2","brief_title":"A Study of DB-1310 in Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT05785741 - DB-1310-O-1001","lead_sponsor":"DualityBio Inc.","biomarkers":" ERBB3","pipe":"","alterations":" ","tags":["ERBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e DB-1310"],"overall_status":"Recruiting","enrollment":" Enrollment 287","initiation":"Initiation: 04/10/2023","start_date":" 04/10/2023","primary_txt":" Primary completion: 08/31/2026","primary_completion_date":" 08/31/2026","study_txt":" Completion: 08/31/2026","study_completion_date":" 08/31/2026","last_update_posted":"2024-02-23"}]